Identification of Plasmid-Mediated Colistin Resistance in Multidrug-Resistant Gram-Negative Rods Isolated From

Yusra Wahab1, Humera Javed2, Shah Jahan3

  • 1Pathology and Laboratory Medicine, Faisalabad Medical University, Faisalabad, PAK.

Cureus
|July 23, 2026
PubMed
Abstract

Insights

Colistin resistance in Gram-negative bacteria is a growing concern, especially for immunocompromised patients. This study found 6% colistin resistance, with all resistant isolates carrying the mcr-1 gene, highlighting a significant threat.

Area of Science:

  • Clinical microbiology
  • Infectious diseases
  • Antimicrobial resistance

Background:

  • Antimicrobial resistance (AMR) is a major threat to immunocompromised patients, particularly multidrug-resistant (MDR) Gram-negative bacteria.
  • Colistin is a last-resort antibiotic, but the emergence of mobilized colistin resistance (mcr) genes threatens its efficacy.

Purpose of the Study:

  • To evaluate the prevalence of phenotypic colistin resistance in clinical isolates from immunocompromised patients.
  • To determine the presence of mcr genes (mcr-1 to mcr-5) in colistin-resistant isolates.

Main Methods:

  • A descriptive cross-sectional study of 100 MDR Gram-negative rods from immunocompromised patients.
  • Colistin susceptibility testing using the colistin broth disk elution (CBDE) method.
  • Polymerase chain reaction (PCR) to screen for mcr-1 to mcr-5 genes.

Main Results:

  • A 6% prevalence of phenotypic colistin resistance was observed.
  • All colistin-resistant isolates (6/6) harbored the mcr-1 gene; no other mcr genes were detected.
  • Highest resistance rates were found in Klebsiella pneumoniae (16%) and Acinetobacter baumannii (7.7%).

Conclusions:

  • The presence of mcr-1 in all resistant isolates suggests plasmid-mediated transmission, posing a significant risk to immunocompromised populations.
  • The CBDE method is a reliable diagnostic tool for colistin resistance, even in resource-limited settings.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...